3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Sarcoma
35
Gastrointestinal
35
Gynecologic
5
Genitourinary
5
Dermatologic
5
Head & Neck
4
Endocrine
4
Thoracic
3
CNS
3
Breast
3
Other solid neoplasm
2
NET
2
Plasma cell
1
Other hematologic neoplasm
1
Conditions
Neuroendocrine Tumors
73
Pheochromocytoma
8
Gastro-enteropancreatic neuroendocrine tumor
8
Paraganglioma
7
Carcinoma, Neuroendocrine
7
Carcinoid Tumor
7
Adenoma, Islet Cell
7
Thyroid Neoplasms
5
Sarcoma
5
Pancreatic Neoplasms
5
Neoplasms
5
Melanoma
5
Breast Neoplasms
5
Prostatic Neoplasms
4
Neuroblastoma
4
Neoplasm Metastasis
4
Mesothelioma
4
Carcinoma, Merkel Cell
4
Carcinoma
4
Stomach Neoplasms
3
Ovarian Neoplasms
3
Neuroectodermal Tumors, Primitive
3
Meningioma
3
Liver Neoplasms
3
Colorectal Neoplasms
3
Colonic Neoplasms
3
Cholangiocarcinoma
3
Central Nervous System Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Medullary
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Gastrointestinal Stromal Tumors
×
NET
×
90 days
×
Clear all
NCT02012699
2026-05-05
iCaRe2
University of Nebraska
Recruiting
999,999 enrolled
NCT05500391
2026-03-18
SUR-CAN
Centre Oscar Lambret
Phase 2
Recruiting
88 enrolled